Ads
related to: acute myeloid leukemia news- Treatment Option
Visit The Physician Website To
Learn More About This Treatment.
- Mechanism Of Action
Learn How To Treat Patients
With Ph+ CML-CP Today.
- Efficacy Information
Physicians, See How This Treatment
May Help Your Patients Today.
- View Patient Profiles
Patients Experience Treatment
Intolerance & Suboptimal Responses
- Safety Profile
Physicians, See Important Safety
Information About This Treatment.
- $0 Co-Pay Information
Patients With Private Insurance
Could Save On Their Prescription.
- Treatment Option
Search results
HanxBio announces the publication of a research paper in Scientific Reports on preclinical...
FOX 59 Indianapolis· 3 days agoHanxBio today announced that it has published a research article titled "Narazaciclib, a novel...
FDA grants breakthrough status for Kura Oncology's AML drug candicate By Investing.com
Investing.com· 4 days agoFood and Drug Administration (FDA) has awarded Breakthrough Therapy Designation to its drug...
Ipsen, Skyhawk to develop RNA-targeting pills for rare brain diseases
BioPharma Dive via Yahoo Finance· 4 days agoIpsen, for instance, formed a partnership with Accent Therapeutics in 2021 develop a drug for acute ...
Study reveals insights into DDX41 protein's role in blood cancer pathogenesis
Medical Xpress· 3 days agoA study led by Professors Hongtae Kim and JaYil Lee from the Department of Biological Sciences, in collaboration with researchers from the Catholic University of Korea, sheds light on the pivotal ...
Deverra Therapeutics Granted FDA Fast Track Designation for DVX101
Digital Journal· 2 days agoDesignation Validates Preliminary Data and Supports Accelerated Drug Development SEATTLE, WA / ACCESSWIRE / April 24, 2024 / Deverra Therapeutics, Inc., a clinical-stage biotechnology company ...
Why Big Pharma Is Following Novartis' Lead In A $25 Billion Market
Investor's Business Daily· 1 day agoActinium is working on a radiopharmaceutical-based treatment foracute myeloid leukemia. But more...
Secondary cancer: Why breast cancer survivors have a higher risk
Medical News Today· 1 day agoThe age of cancer diagnosis appears to affect second cancer risk, especially for women, as does economic status. In it, researchers from the University of Cambridge in England report that women ...
Kura Oncology Receives Breakthrough Therapy Designation for Ziftomenib in NPM1-Mutant AML
Morningstar· 4 days agoFood and Drug Administration (FDA) for the treatment of patients with relapsed/refractory (R/R) NPM1-mutant acute myeloid leukemia (AML ...
Chandler community rallying around toddler who needs life-saving bone marrow transplant
KTVK 3TV Phoenix· 6 days agoFamily and friends are rallying around a toddler who is battling cancer, hoping he will soon receive...
Kura Oncology, Inc. (NASDAQ:KURA) Stock Holdings Lessened by Mirae Asset Global Investments Co. Ltd.
ETF DAILY NEWS· 12 hours agoMirae Asset Global Investments Co. Ltd. lessened its holdings in shares of Kura Oncology, Inc. (NASDAQ:KURA – Free Report) by 5.7% in the fourth quarter, according to the company in its most ...
Ads
related to: acute myeloid leukemia news